Threshold retinopathy of prematurity. Transition from cryopexy to laser treatment.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 8747442.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The authors studied the effectiveness of laserpexy versus cryopexy for treatment of acute retinopathy of prematurity. Seventy-six eyes in 41 patients were treated for acute retinopathy of prematurity from January 1991 to April 1994. Fifty-six eyes in 30 patients had zone 2 disease. Of these 30 patients, 11 received laser treatment and 20 received cryopexy treatment; there was at least one anatomically successful eye in each patient. Twenty eyes in ten patients had zone 1 disease. Seven patients had bilateral laser treatment. Three patients had bilateral cryopexy. In seven eyes with zone 1 disease, five were treated successfully with laser. None of the three eyes with zone 1 disease treated with cryopexy were successful. Laserpexy and cryopexy are of equal efficacy in treating zone 2 disease. There is a tendency that suggests that laserpexy is more effective than cryopexy in treating zone 1 disease. Diode and argon lasers are of equal efficacy in treating zone 1 disease.
Medical subject headings
- Cryosurgery
- Laser Coagulation
- Retina
- Retinopathy of Prematurity